AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 4 698-R703, Copyright © 1991 by American Physiological Society

ARTICLES

Hyperglycemia induces accumulation of glucose in human skeletal muscle

A. Katz, I. Raz, M. K. Spencer, R. Rising and D. M. Mott
Department of Kinesiology, University of Illinois, Urbana 61801.

The effect of hyperglycemia on whole body substrate utilization and the metabolic profile of skeletal muscle has been investigated. Eight glucose-tolerant men were infused with somatostatin (S) for 190 min. During the last 120 min of S infusion, glucose was infused to achieve a steady-state plasma level of 26 mmol/l. Biopsies were obtained from the quadriceps femoris muscle immediately before and 35 and 120 min after induction of hyperglycemia. Steady-state glucose disposal during hyperglycemia averaged (+/- SE) 33.8 +/- 3.2 mumol.kg fat-free mass-1.min-1, and approximately 70% of the glucose disposal was accounted for by skeletal muscle. Intracellular glucose increased from 0.9 +/- 0.2 mmol/kg dry wt during S to 9.5 +/- 2.5 during hyperglycemia (P less than 0.01). It was estimated that approximately 35% of the glucose taken up by muscle during 120 min of hyperglycemia was not phosphorylated. Muscle contents of alpha-D-glucose 1,6-diphosphate, D-glucose 6-phosphate, ATP, ADP, and AMP (both of which are based on the phosphocreatine-to-creatine ratio), which have been shown to inhibit hexokinase in vitro, did not change significantly during hyperglycemia, nor were there any significant changes in any of the other postphosphofructokinase intermediates, D-fructose 2,6-diphosphate, and citrate. Hyperglycemia did not alter the fractional activities of glycogen synthase or phosphorylase, nor total phosphorylase activity. However, hyperglycemia resulted in a 55% increase in glycogen synthase-specific activity (P less than 0.01). It is concluded that hyperglycemia results in a marked increase in muscle glucose.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Christopher, C. Rantzau, Z.-P. Chen, R. Snow, B. Kemp, and F. P. Alford Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1131 - E1140. [Abstract] [Full Text] [PDF]

				M. J. Christopher, C. Rantzau, G. McConell, B. E. Kemp, and F. P. Alford Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs J Appl Physiol, March 1, 2005; 98(3): 930 - 939. [Abstract] [Full Text] [PDF]

				R. Roussel, P. G. Carlier, J.-J. Robert, G. Velho, and G. Bloch 13C/31P NMR studies of glucose transport in human skeletal muscle PNAS, February 3, 1998; 95(3): 1313 - 1318. [Abstract] [Full Text] [PDF]

				G. W. Cline, B. M. Jucker, Z. Trajanoski, A. J. M. Rennings, and G. I. Shulman A novel 13C NMR method to assess intracellular glucose concentration in muscle, in vivo Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E381 - E389. [Abstract] [Full Text] [PDF]

				S. M. Weltan, A. N. Bosch, S. C. Dennis, and T. D. Noakes Preexercise muscle glycogen content affects metabolism during exercise despite maintenance of hyperglycemia Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E83 - E88. [Abstract] [Full Text] [PDF]